Alphamab Oncology (STU:3NK) Total Inventories : €8.34 Mil (As of Jun. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Alphamab Oncology Total Inventories?

Alphamab Oncology's total inventories for the quarter that ended in Jun. 2024 was €8.34 Mil. Alphamab Oncology's average total inventories from the quarter that ended in Dec. 2023 to the quarter that ended in Jun. 2024 was €9.23 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Alphamab Oncology's Net-Net Working Capital per share for the quarter that ended in Jun. 2024 was €0.13.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Alphamab Oncology's Days Inventory for the six months ended in Jun. 2024 was 426.92.

Inventory Turnover measures how fast the company turns over its inventory within a year. Alphamab Oncology's Inventory Turnover for the quarter that ended in Jun. 2024 was 0.43.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Alphamab Oncology's Inventory-to-Revenue for the quarter that ended in Jun. 2024 was 0.42.

Alphamab Oncology Total Inventories Historical Data

The historical data trend for Alphamab Oncology's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alphamab Oncology Total Inventories Chart

Alphamab Oncology Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Inventories

Get a 7-Day Free Trial

5.57

8.05

8.75

10.11

10.73

Alphamab Oncology Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Inventories	Get a 7-Day Free Trial										8.75	8.11	10.11	8.34	10.73

Alphamab Oncology Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Alphamab Oncology (STU:3NK) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Alphamab Oncology's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2024 is

	Net-Net Working Capital Per Share (Q: Jun. 2024 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(186.523	+	0.75 * 1.686	+	0.5 * 8.344	-	65.724
-	0	-	0)	/	963.988
=	0.13

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Alphamab Oncology's Days Inventory for the six months ended in Jun. 2024 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Jun. 2024 )	/	Cost of Goods Sold (Q: Jun. 2024 )	*	Days in Period
	=	9.2285	/	3.945	*	365 / 2
	=	426.92

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Alphamab Oncology's Inventory Turnover for the quarter that ended in Jun. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Jun. 2024 )	/	Average Total Inventories (Q: Jun. 2024 )
	=	3.945	/	9.2285
	=	0.43

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Alphamab Oncology's Inventory to Revenue for the quarter that ended in Jun. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Jun. 2024 )	/	Revenue (Q: Jun. 2024 )
	=	9.2285	/	22.225
	=	0.42

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Alphamab Oncology Total Inventories Related Terms

Thank you for viewing the detailed overview of Alphamab Oncology's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Alphamab Oncology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alphamab Oncology (STU:3NK) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

09966:Hong Kong

Address

No. 175 Fangzhou Road, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN, 215127

Website

https://www.alphamabonc.com

Alphamab Oncology is a clinical-stage biopharmaceutical company in China with a fully integrated proprietary biologics platform in bispecifics and protein engineering. The company through its subsidiaries is engaged in the discovery, development manufacturing, and commercialization of biotherapeutics for cancer treatment. Its product pipeline includes various drug candidates such as KN035 (Envida), KN046, KN026, JSKN003, and KN019 among others in different stages of development.

Alphamab Oncology Headlines

No Headlines